Evidence map›Paper›PMID 37794453›Full record

ArticleNeurological research and practice2023

Independent external validation of a stroke recurrence score in patients with embolic stroke of undetermined source.

Thies Ingwersen, Manuel C Olma, Eckhard Schlemm, Carola Mayer, Bastian Cheng, Serdar Tütüncü, Paulus Kirchhof, Roland Veltkamp, Joachim Röther, Ulrich Laufs and 5 more

Registry-linked trialOpen access · diamondAbstract read
In one paragraph

Article in Neurological research and practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02204267 (Impact of Standardized MONitoring for Detection of Atrial Fibrillation in Ischemic Stroke), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 75% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02204267 nacompletednot on this map

Impact of Standardized MONitoring for Detection of Atrial Fibrillation in Ischemic Stroke

TypeinterventionalSponsorCharite University, Berlin, GermanyRan2014 to 2020Enrolled3,470ConditionsStroke, Atrial FibrillationArmsprolonged ECG monitoring, ECG
3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 11 institutions in 3 countries.

Thies IngwersenDepartment of Neurology, University Medical Centre Hamburg-Eppendorf (UKE), Hamburg, Germany. thi.ingwersen@uke.de.ORCID http://orcid.org/0000-0002-8646-9795
Manuel C OlmaCenter for Stroke Research Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany.
Eckhard SchlemmDepartment of Neurology, University Medical Centre Hamburg-Eppendorf (UKE), Hamburg, Germany.
Carola MayerDepartment of Neurology, University Medical Centre Hamburg-Eppendorf (UKE), Hamburg, Germany.
Bastian ChengDepartment of Neurology, University Medical Centre Hamburg-Eppendorf (UKE), Hamburg, Germany.
Serdar TütüncüCenter for Stroke Research Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany.
Paulus KirchhofDepartment of Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany.
Roland VeltkampDepartment of Neurology, Alfried Krupp Hospital, Essen, Germany.
Joachim RötherDepartment of Neurology, Asklepios Hospital Altona, Hamburg, Germany.
Ulrich LaufsDepartment of Cardiology, University Hospital Leipzig, Hamburg, Germany.
Darius G NabaviDepartment of Neurology, Vivantes Hospital Neukölln, Berlin, Germany.
George NtaiosDepartment of Internal Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.
Matthias EndresCenter for Stroke Research Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany.
Karl Georg Haeusler *Department of Neurology, Universitätsklinikum Würzburg (UKW), Würzburg, Germany.
Götz Thomalla *Department of Neurology, University Medical Centre Hamburg-Eppendorf (UKE), Hamburg, Germany.
Universität Hamburg · DEAlfried Krupp Hospital · DEAsklepios Klinik Altona · DEBerlin Institute of Health at Charité - Universitätsmedizin Berlin · DECharité - Universitätsmedizin Berlin · DEGerman Center for Neurodegenerative Diseases · DEGerman Centre for Cardiovascular Research · DEUniversitäts-Kinderklinik Würzburg · DEUniversity Hospital Leipzig · DEUniversity of Thessaly · GRVivantes Klinikum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEmbolic stroke of undetermined source (ESUS) accounts for a substantial proportion of ischaemic strokes. A stroke recurrence score has been shown to predict the risk of recurrent stroke in patients with ESUS based on a combination of clinical and imaging features. This study aimed to externally validate the performance of the ESUS recurrence score using data from a randomized controlled trial.

methodsThe validation dataset consisted of eligible stroke patients with available magnetic resonance imaging (MRI) data enrolled in the PreDAFIS sub-study of the MonDAFIS study. The score was calculated using three variables: age (1 point per decade after 35 years), presence of white matter hyperintensities (2 points), and multiterritorial ischaemic stroke (3 points). Patients were assigned to risk groups as described in the original publication. The model was evaluated using standard discrimination and calibration methods.

resultsOf the 1054 patients, 241 (22.9%) were classified as ESUS. Owing to insufficient MRI quality, three patients were excluded, leaving 238 patients (median age 65.5 years [IQR 20.75], 39% female) for analysis. Of these, 30 (13%) patients experienced recurrent ischaemic stroke or transient ischemic attack (TIA) during a follow-up period of 383 patient-years, corresponding to an incidence rate of 7.8 per 100 patient-years (95% CI 5.3-11.2). Patients with an ESUS recurrence score value of ≥ 7 had a 2.46 (hazard ratio (HR), 95% CI 1.02-5.93) times higher risk of stroke recurrence than patients with a score of 0-4. The cumulative probability of stroke recurrence in the low-(0-4), intermediate-(5-6), and high-risk group (≥ 7) was 9%, 13%, and 23%, respectively (log-rank test, χ

conclusionsThis external validation of a published scoring system supports a threshold of ≥ 7 for identifying ESUS patients at high-risk of stroke recurrence. However, further adjustments may be required to improve the model's performance in independent cohorts. The use of risk scores may be helpful in guiding extended diagnostics and further trials on secondary prevention in patients with ESUS.

trial registrationClinical Trials, NCT02204267. Registered 30 July 2014, https://clinicaltrials.gov/ct2/show/NCT02204267 .

Indexed as

Embolic stroke of undetermined sourceESUSExternal validationIschemic strokeStroke recurrenceStroke recurrence score

Identifiers

PMID37794453
PMCPMC10552210
OpenAlexW4387345557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.